Previous studies have described genomic alterations in human HCC, with recurrent loss of the TP53 and RB tumor suppressor genes, and amplification or overexpression of the MYC oncogene in 40–60% of HCCs [4–6]. Here, MYC is linked to hepatocellular carcinoma.